Onward Medical N.V.
Develops neurostimulation therapies to restore function for people with spinal cord injury.
ONWD | AS
Overview
Corporate Details
- ISIN(s):
- NL0015000HT4
- LEI:
- 9845007A2CC4C8BFSB80
- Country:
- Netherlands
- Address:
- Schimmelt 2, 5611ZX Eindhoven
- Website:
- https://www.onwd.com/
- Sector:
- Manufacturing
Description
Onward Medical is a neurotechnology company that develops therapies to restore movement, function, and independence for people with spinal cord injury (SCI). The company's commercial product, the ARC-EX System, is an external, non-invasive spinal cord stimulation therapy indicated to improve hand sensation and strength for individuals with chronic cervical SCI. The system is used in rehabilitation clinics and is also cleared for home use. Onward Medical is also advancing its investigational implantable platform, the ARC-IM System, which is designed to address other functional deficits, including blood pressure regulation, following spinal cord injury.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-09 15:14 |
ONWARD Announces First Patient Enrollment in HemON Study and First-in-Human Use…
|
English | PDF • 303.0 KB | ||
| 2022-05-03 15:45 | English | ZIP • 12.8 MB | |||
| 2022-04-29 08:20 |
Convocation of the 2022 Annual General Meeting of Shareholders and Proposed Res…
|
English | PDF • 176.0 KB | ||
| 2022-04-26 08:19 |
ONWARD Reports 2021 Full Year Financial and Operating Results
|
English | PDF • 290.3 KB | ||
| 2022-04-14 08:19 |
Bryan Garnier Initiates Coverage of ONWARD with a Buy Rating and Target Price o…
|
English | PDF • 137.2 KB | ||
| 2022-04-07 08:46 |
ONWARD Medical’s Parkinson’s Therapy Published in New England Journal of Medic…
|
English | PDF • 132.5 KB | ||
| 2022-03-28 08:14 |
ONWARD Adds New Brain-Spine Interface and Parkinson’s Disease IP to License Agr…
|
English | PDF • 146.2 KB | ||
| 2022-03-28 08:14 |
ONWARD Adds New Brain-Spine Interface and Parkinson’s Disease IP to License Agr…
|
English | PDF • 126.7 KB | ||
| 2022-03-22 08:18 |
ONWARD Confirms Cash Runway through End of 2024
|
English | PDF • 124.8 KB | ||
| 2022-03-22 08:18 |
ONWARD Confirms Cash Runway through End of 2024
|
English | PDF • 126.7 KB | ||
| 2022-02-08 08:19 |
ONWARD Medical’s Technology Enables Walking and Standing After Severe Spinal Co…
|
English | PDF • 133.6 KB | ||
| 2021-12-16 08:41 |
ONWARD Announces Completion of Enrollment in the Up-LIFT Pivotal Trial of ARC T…
|
English | PDF • 88.9 KB | ||
| 2021-12-16 08:41 |
ONWARD Announces Completion of Enrollment in the Up-LIFT Pivotal Trial of ARC T…
|
English | PDF • 38.3 KB | ||
| 2021-11-24 08:48 |
Mid-Stabilisation Period Announcement
|
Dutch | DOCX • 53.0 KB | ||
| 2021-11-24 08:48 |
Mid-Stabilisation Period Announcement
|
English | DOCX • 54.7 KB |
Automate Your Workflow. Get a real-time feed of all Onward Medical N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Onward Medical N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Onward Medical N.V. via our API.
Peer Companies
